Skip to main content

Intraoperative detection of isocitrate dehydrogenase mutations in human gliomas using a miniature mass spectrometer

Abstract

Knowledge of the isocitrate dehydrogenase (IDH) mutation status of glioma patients could provide insights for decision-making during brain surgery. However, pathology is not able to provide such information intraoperatively. Here we describe the first application of a miniature mass spectrometer (MS) to the determination of IDH mutation status in gliomas intraoperatively. The instrumentation was modified to be compatible with use in the operating room. Tandem MS was performed on the oncometabolite, 2-hydroxyglutarate, and a reference metabolite, glutamate, which is not involved in the IDH mutation. Ratios of fragment ion intensities were measured to calculate an IDH mutation score, which was used to differentiate IDH mutant and wild-type tissues. The results of analyzing 25 biopsies from 13 patients indicate that reliable determination of IDH mutation status was achieved (p = 0.0001, using the Kruskal-Wallis non-parametric test). With its small footprint and low power consumption and noise level, this application of miniature mass spectrometers represents a simple and cost-effective platform for an important intraoperative measurement.

Graphical abstract

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2

References

  1. Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016;131(6):803–20. https://doi.org/10.1007/s00401-016-1545-1.

    Article  PubMed  Google Scholar 

  2. Chen R, Ravindra VM, Cohen AL, Jensen RL, Salzman KL, Prescot AP, et al. Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomas. Neurosurg Focus. 2015;38(3):E2. https://doi.org/10.3171/2015.1.FOCUS14745.

    Article  PubMed  Google Scholar 

  3. Patel T, Bander ED, Venn RA, Powell T, Cederquist GY, Schaefer PM, et al. The Role of Extent of Resection in IDH1 Wild-Type or Mutant Low-Grade Gliomas. Neurosurgery. 2018;82(6):808–14. https://doi.org/10.1093/neuros/nyx265.

    Article  PubMed  Google Scholar 

  4. Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 2009;462(7274):739–44. https://doi.org/10.1038/nature08617.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Miller JJ, Shih HA, Andronesi OC, Cahill DP. Isocitrate dehydrogenase-mutant glioma: Evolving clinical and therapeutic implications. Cancer. 2017;123(23):4535–46. https://doi.org/10.1002/cncr.31039.

    Article  CAS  PubMed  Google Scholar 

  6. Andronesi OC, Kim GS, Gerstner E, Batchelor T, Tzika AA, Fantin VR, et al. Detection of 2-hydroxyglutarate in IDH-mutated glioma patients by in vivo spectral-editing and 2D correlation magnetic resonance spectroscopy. Sci Transl Med. 2012;4(116):116ra114. https://doi.org/10.1126/scitranslmed.3002693.

    Article  CAS  Google Scholar 

  7. Santagata S, Eberlin LS, Norton I, Calligaris D, Feldman DR, Ide JL, et al. Intraoperative mass spectrometry mapping of an onco-metabolite to guide brain tumor surgery. Proc Natl Acad Sci U S A. 2014;111(30):11121–6. https://doi.org/10.1073/pnas.1404724111.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. McDonnell LA, Heeren RM. Imaging mass spectrometry. Mass Spectrom Rev. 2007;26(4):606–43. https://doi.org/10.1002/mas.20124.

    Article  CAS  PubMed  Google Scholar 

  9. Longuespee R, Wefers AK, De Vita E, Miller AK, Reuss DE, Wick W, et al. Rapid detection of 2-hydroxyglutarate in frozen sections of IDH mutant tumors by MALDI-TOF mass spectrometry. Acta Neuropathol Commun. 2018;6(1):21. https://doi.org/10.1186/s40478-018-0523-3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Takats Z, Wiseman JM, Gologan B, Cooks RG. Mass spectrometry sampling under ambient conditions with desorption electrospray ionization. Science. 2004;306(5695):471–3. https://doi.org/10.1126/science.1104404.

    Article  CAS  PubMed  Google Scholar 

  11. Cody RB, Laramee JA, Durst HD. Versatile new ion source for the analysis of materials in open air under ambient conditions. Anal Chem. 2005;77(8):2297–302. https://doi.org/10.1021/ac050162j.

    Article  CAS  PubMed  Google Scholar 

  12. Brown HM, Pirro V, Cooks RG. From DESI to the MasSpec Pen: Ambient Ionization Mass Spectrometry for Tissue Analysis and Intrasurgical Cancer Diagnosis. Clin Chem. 2018;64(4):628–30. https://doi.org/10.1373/clinchem.2017.281923.

    Article  CAS  PubMed  Google Scholar 

  13. He J, Sun C, Li T, Luo Z, Huang L, Song X, et al. A Sensitive and Wide Coverage Ambient Mass Spectrometry Imaging Method for Functional Metabolites Based Molecular Histology. Adv Sci. 2018;5(11):1800250. https://doi.org/10.1002/advs.201800250.

    Article  CAS  Google Scholar 

  14. Robichaud G, Barry JA, Muddiman DC. IR-MALDESI mass spectrometry imaging of biological tissue sections using ice as a matrix. J Am Soc Mass Spectrom. 2014;25(3):319–28. https://doi.org/10.1007/s13361-013-0787-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Van Berkel GJ, Kertesz V, Koeplinger KA, Vavrek M, Kong AN. Liquid microjunction surface sampling probe electrospray mass spectrometry for detection of drugs and metabolites in thin tissue sections. J Mass Spectrom. 2008;43(4):500–8. https://doi.org/10.1002/jms.1340.

    Article  CAS  PubMed  Google Scholar 

  16. Wang H, Manicke NE, Yang Q, Zheng L, Shi R, Cooks RG, et al. Direct Analysis of Biological Tissue by Paper Spray Mass Spectrometry. Anal Chem. 2011;83(4):1197–201. https://doi.org/10.1021/ac103150a.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Zhang J, Rector J, Lin JQ, Young JH, Sans M, Katta N, et al. Nondestructive tissue analysis for ex vivo and in vivo cancer diagnosis using a handheld mass spectrometry system. Sci Transl Med. 2017;9(406). https://doi.org/10.1126/scitranslmed.aan3968.

  18. Balog J, Sasi-Szabo L, Kinross J, Lewis MR, Muirhead LJ, Veselkov K, et al. Intraoperative Tissue Identification Using Rapid Evaporative Ionization Mass Spectrometry. Sci Transl Med. 2013;5(194):194ra193. https://doi.org/10.1126/scitranslmed.3005623.

    Article  CAS  Google Scholar 

  19. Alfaro CM, Pirro V, Keating MF, Hattab EM, Cooks RG, Cohen-Gadol AA. Intraoperative assessment of isocitrate dehydrogenase mutation status in human gliomas using desorption electrospray ionization-mass spectrometry. J Neurosurg. 2019:1–8. https://doi.org/10.3171/2018.8.JNS181207.

  20. Austin DE, Lammert SA. Mass Analyzer Miniaturization. In: The Encyclopedia of Mass Spectrometry, vol. 7. 1st ed: Elsevier; 2009.

  21. Pu F, Alfaro CM, Pirro V, Xie Z, Ouyang Z, Cooks RG. Rapid determination of isocitrate dehydrogenase mutation status of human gliomas by extraction nanoelectrospray using a miniature mass spectrometer. Anal Bioanal Chem. 2019;411(8):1503–8. https://doi.org/10.1007/s00216-019-01632-5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Zou R, Cao W, Chong L, Hua W, Xu H, Mao Y, et al. Point-of-Care Tissue Analysis Using Miniature Mass Spectrometer. Anal Chem. 2019;91(1):1157–63. https://doi.org/10.1021/acs.analchem.8b04935.

    Article  CAS  PubMed  Google Scholar 

  23. Ren Y, Liu J, Li L, McLuckey MN, Ouyang Z. Direct Mass Spectrometry Analysis of Untreated Samples of Ultralow Amounts Using Extraction Nano-Electrospray. Anal Methods. 2013;5(23). https://doi.org/10.1039/C3AY41149D.

Download references

Acknowledgments

The authors thank clinical research nurses Lauren Snyder and Heather Cero at Goodman Campbell Brain and Spin (Indianapolis, IN) for patient consent, providing clinical data, and IRB monitoring; Clint Alfaro and Tsdale Mehari for assistance in sample preparation; Robert Schrader for assistance with instrumentation; Zhuoer Xie for the table of contents figure; and PURSPEC Technologies Inc. for instrumentation support.

Funding

This study received funding from the Purdue University Center for Cancer Research Small Grants Program; from National Institute of General Medical Sciences of the NIH under award number R44GM119584.

Author information

Affiliations

Authors

Corresponding author

Correspondence to R. Graham Cooks.

Ethics declarations

Biopsies for tissue analysis were obtained from human subjects undergoing tumor resection for suspected glioma at IU Health Methodist Hospital, after they had provided written informed consent to participate in the research study, following an IUSM IRB approved protocol (IRB No. 1410342262). No results were shared with the neurosurgeons during the surgical resection so as not to affect the standard of care.

Conflict of interest

Zheng Ouyang is the founder of PURSPEC Technologies Inc. All other authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(PDF 458 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Brown, H.M., Pu, F., Dey, M. et al. Intraoperative detection of isocitrate dehydrogenase mutations in human gliomas using a miniature mass spectrometer. Anal Bioanal Chem 411, 7929–7933 (2019). https://doi.org/10.1007/s00216-019-02198-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-019-02198-y

Keywords

  • Molecular cancer diagnostics
  • Ambient ionization mass spectrometry
  • Isocitrate dehydrogenase mutation
  • Miniature mass spectrometry
  • Point-of-care diagnostics